Genetic Vaccines and Therapy | Most Viewed

Submit a manuscript Register

Explore journal

Articles

Display/download options Articles per page: 25 | 50 | 100

Display options

Editor's summary Citation

Download options

Send
To

	All
	1. 274 Accesses	Review DNA vaccines: designing strategies against parasitic infections Catherine Ivory, Kris Chadee Genetic Vaccines and Therapy 2004, 2:17 (3 December 2004) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central
	2. 269 Accesses	Short paper DNA-vaccination via tattooing induces stronger humoral and cellular immune responses than intramuscular delivery supported by molecular adjuvants Dana Pokorna, Ivonne Rubio, Martin Müller Genetic Vaccines and Therapy 2008, 6:4 (7 February 2008) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central \| Editor’s summary The tattoo delivery of DNA vaccines is cost effective, induces a greater immune response, and is a more efficient delivery strategy for laboratory studies than intramuscular injection.
	3. 266 Accesses	Short report Hepatitis C virus genotype 3a with phylogenetically distinct origin is circulating in Pakistan Irshad-ur Rehman, Muhammad Idrees, Muhammad Ali, Liaqat Ali, Sadia Butt, Abrar Hussain, Haji Akbar, Samia Afzal Genetic Vaccines and Therapy 2011, 9:2 (6 January 2011) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central
	4. 253 Accesses	Review DNA vaccines: improving expression of antigens Helen S Garmory, Katherine A Brown, Richard W Titball Genetic Vaccines and Therapy 2003, 1:2 (16 September 2003) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central
	5. 254 Accesses	Review Clostridial spores as live 'Trojan horse' vectors for cancer gene therapy: comparison with viral delivery systems Ming Q Wei, Ruimei Ren, David Good, Jozef Anné Genetic Vaccines and Therapy 2008, 6:8 (17 February 2008) Abstract \| Full text \| PDF \| PubMed
	6. 240 Accesses	Review The use of retroviral vectors for gene therapy-what are the risks? A review of retroviral pathogenesis and its relevance to retroviral vector-mediated gene delivery Donald S Anson Genetic Vaccines and Therapy 2004, 2:9 (13 August 2004) Abstract \| Full text \| PDF \| PubMed
	7. 212 Accesses	Review Antiviral drugs against hepatitis C virus Sidra Rehman, Usman A Ashfaq, Tariq Javed Genetic Vaccines and Therapy 2011, 9:11 (23 June 2011) Abstract \| Full text \| PDF \| PubMed
	8. 210 Accesses	Research Molecular Relationship between Field and Vaccine Strain of Measles Virus and its Persistence in Pakistan Masaud Shah, Sulaiman Shams, Ziaur Rahman Genetic Vaccines and Therapy 2012, 10:1 (30 January 2012) Abstract \| Provisional PDF \| PubMed
	9. 207 Accesses	Research Establishment of stable Huh-7 cell lines expressing various hepatitis C virus genotype 3a protein: an in-vitro testing system for novel anti-HCV drugs Sadia Butt, Muhammad Idrees, Irshad-ur Rehman, Liaqat Ali, Abrar Hussain, Muhammad Ali, Naveed Ahmed, Sana Saleem, Madiha Fayyaz Genetic Vaccines and Therapy 2011, 9:12 (28 June 2011) Abstract \| Full text \| PDF \| PubMed
	10. 174 Accesses	Review In-vitro model systems to study Hepatitis C Virus Usman Ashfaq, Shaheen N Khan, Zafar Nawaz, Sheikh Riazuddin Genetic Vaccines and Therapy 2011, 9:7 (6 April 2011) Abstract \| Full text \| PDF \| PubMed
	11. 172 Accesses	Research Production and characterization of amplified tumor-derived cRNA libraries to be used as vaccines against metastatic melanomas Jean-Philippe Carralot, Benjamin Weide, Oliver Schoor, Jochen Probst, Birgit Scheel, Regina Teufel, Ingmar Hoerr, Claus Garbe, Hans-Georg Rammensee, Steve Pascolo Genetic Vaccines and Therapy 2005, 3:6 (22 August 2005) Abstract \| Full text \| PDF \| PubMed
	12. 171 Accesses	Research DNA vaccine constructs against enterovirus 71 elicit immune response in mice Wong Tung, Sazaly Bakar, Zamberi Sekawi, Rozita Rosli Genetic Vaccines and Therapy 2007, 5:6 (19 April 2007) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central
	13. 170 Accesses	Research Occult HCV or delayed viral clearance from lymphocytes of Chronic HCV genotype 3 patients after interferon therapy Ambreen G Muazzam, Saleem Qureshi, Atika Mansoor, Lubna Ali, Musarrat Iqbal, Saima Siddiqi, Khalid M Khan, Kehkashan Mazhar Genetic Vaccines and Therapy 2011, 9:14 (6 September 2011) Abstract \| Full text \| PDF \| PubMed
	14. 149 Accesses	Research HCV entry receptors as potential targets for siRNA-based inhibition of HCV Shah Jahan, Baila Samreen, Saba Khaliq, Bushra Ijaz, Mahwish Khan, Muhammad Siddique, Waqar Ahmad, Sajida Hassan Genetic Vaccines and Therapy 2011, 9:15 (6 September 2011) Abstract \| Full text \| PDF \| PubMed
	15. 140 Accesses	Research Development of avian influenza virus H5 DNA vaccine and MDP-1 gene of Mycobacterium bovis as genetic adjuvant Babak Jalilian, Abdul Omar, Mohd Bejo, Noorjahan Alitheen, Mehdi Rasoli, Sohkichi Matsumoto Genetic Vaccines and Therapy 2010, 8:4 (24 May 2010) Abstract \| Full text \| PDF \| PubMed
	16. 136 Accesses	Research Double suicide genes driven by kinase domain insert containing receptor promoter selectively kill human lung cancer cells Junrong Ma, Mi Li, Longyong Mei, Qinghua Zhou, Lunxu Liu, Xijie Yu, Guowei Che Genetic Vaccines and Therapy 2011, 9:6 (22 March 2011) Abstract \| Full text \| PDF \| PubMed
	17. 133 Accesses	Research Novel non-viral method for transfection of primary leukemia cells and cell lines Frank Schakowski, Peter Buttgereit, Martin Mazur, Angela Märten, Björn Schöttker, Marcus Gorschlüter, Ingo GH Schmidt-Wolf Genetic Vaccines and Therapy 2004, 2:1 (12 January 2004) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central
	18. 132 Accesses	Methodology Electroporation by nucleofector is the best nonviral transfection technique in human endothelial and smooth muscle cells Nina Iversen, Baard Birkenes, Kari Torsdalen, Srdjan Djurovic Genetic Vaccines and Therapy 2005, 3:2 (18 April 2005) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central
	19. 130 Accesses	Research Influence of insulators on transgene expression from integrating and non-integrating lentiviral vectors Nicolas Grandchamp, Dorothée Henriot, Stéphanie Philippe, Lahouari Amar, Suzanna Ursulet, Che Serguera, Jacques Mallet, Chamsy Sarkis Genetic Vaccines and Therapy 2011, 9:1 (4 January 2011) Abstract \| Full text \| PDF \| PubMed
	20. 130 Accesses	Short report A comparison of multiple shRNA expression methods for combinatorial RNAi Glen J Mcintyre, Allison J Arndt, Kirsten M Gillespie, Wendy M Mak, Gregory C Fanning Genetic Vaccines and Therapy 2011, 9:9 (17 April 2011) Abstract \| Full text \| PDF \| PubMed
	21. 125 Accesses	Research A DNA vaccine against tuberculosis based on the 65 kDa heat-shock protein differentially activates human macrophages and dendritic cells Luís H Franco, Pryscilla F Wowk, Célio L Silva, Ana PF Trombone, Arlete AM Coelho-Castelo, Constance Oliver, Maria C Jamur, Edson L Moretto, Vânia LD Bonato Genetic Vaccines and Therapy 2008, 6:3 (21 January 2008) Abstract \| Full text \| PDF \| PubMed \| Editor’s summary A DNA vaccine against tuberculosis, effective in mice, is shown to stimulate the human immune response, providing clues for new strategies in human immunotherapy.
	22. 123 Accesses	Research Biodistribution and blood clearance of plasmid DNA administered in arginine peptide complexes Jung Woo, Na Kim, Jai Yang, Sungho Shin Genetic Vaccines and Therapy 2011, 9:13 (17 August 2011) Abstract \| Full text \| PDF \| PubMed
	23. 119 Accesses	Research Recombinant λ-phage nanobioparticles for tumor therapy in mice models Amir Ghaemi, Hoorieh Soleimanjahi, Pooria Gill, Zuhair Hassan, Soodeh Razeghi M Jahromi, Farzin Roohvand Genetic Vaccines and Therapy 2010, 8:3 (12 May 2010) Abstract \| Full text \| PDF \| PubMed
	24. 117 Accesses	Research Therapeutic dendritic cell vaccine preparation using tumor RNA transfection: A promising approach for the treatment of prostate cancer Juliana M Sousa-Canavez, Flavio C Canavez, Kátia RM Leite, Luiz H Camara-Lopes Genetic Vaccines and Therapy 2008, 6:2 (18 January 2008) Abstract \| Full text \| PDF \| PubMed
	25. 111 Accesses	Commentary Skipping the co-expression problem: the new 2A "CHYSEL" technology Pablo de Felipe Genetic Vaccines and Therapy 2004, 2:13 (13 September 2004) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central